| 000 | 02521 a2200697 4500 | ||
|---|---|---|---|
| 005 | 20250516113056.0 | ||
| 264 | 0 | _c20130225 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1872-8421 | ||
| 024 | 7 |
_a10.1016/j.jneuroim.2012.08.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Hongmei | |
| 245 | 0 | 0 |
_aLow dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis. _h[electronic resource] |
| 260 |
_bJournal of neuroimmunology _cJan 2013 |
||
| 300 |
_a28-38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdoptive Transfer _xmethods |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
| 650 | 0 | 4 |
_aButadienes _xpharmacology |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aCoculture Techniques |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEncephalomyelitis, Autoimmune, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aGene Expression _ximmunology |
| 650 | 0 | 4 |
_aInterferon-alpha _xpharmacology |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred Strains |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aMicroglia _xdrug effects |
| 650 | 0 | 4 |
_aMyelin Proteolipid Protein _ximmunology |
| 650 | 0 | 4 |
_aMyelin-Oligodendrocyte Glycoprotein _ximmunology |
| 650 | 0 | 4 |
_aNitriles _xpharmacology |
| 650 | 0 | 4 |
_aPeptide Fragments _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xgenetics |
| 650 | 0 | 4 | _aSecondary Prevention |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTritium |
| 650 | 0 | 4 |
_aZymosan _xtherapeutic use |
| 700 | 1 | _aGonnella, Patricia | |
| 700 | 1 | _aSafavi, Farinaz | |
| 700 | 1 | _aVessal, Ghazal | |
| 700 | 1 | _aNourbakhsh, Bardia | |
| 700 | 1 | _aZhou, Fang | |
| 700 | 1 | _aZhang, Guang-Xian | |
| 700 | 1 | _aRostami, Abdolmohamad | |
| 773 | 0 |
_tJournal of neuroimmunology _gvol. 254 _gno. 1-2 _gp. 28-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jneuroim.2012.08.013 _zAvailable from publisher's website |
| 999 |
_c22134148 _d22134148 |
||